BNP Paribas Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $379M | Buy |
848,047
+178,240
| +27% | +$83.1M | 0.44% | 36 |
|
|
2025
Q4 | $304M | Buy |
669,807
+213,474
| +47% | +$92M | 0.35% | 51 |
|
|
2025
Q3 | $179M | Buy |
456,333
+11,874
| +3% | +$4.96M | 0.46% | 35 |
|
|
2025
Q2 | $198M | Buy |
444,459
+52,446
| +13% | +$24.2M | 0.48% | 36 |
|
|
2025
Q1 | $190M | Buy |
392,013
+2,356
| +0.6% | +$1.1M | 0.51% | 33 |
|
|
2024
Q4 | $157M | Sell |
389,657
-6,362
| -2% | -$2.95M | 0.39% | 51 |
|
|
2024
Q3 | $184M | Sell |
396,019
-11,591
| -3% | -$5.57M | 0.46% | 41 |
|
|
2024
Q2 | $191M | Sell |
407,610
-79,265
| -16% | -$34.4M | 0.49% | 34 |
|
|
2024
Q1 | $204M | Sell |
486,875
-114,639
| -19% | -$48.5M | 0.54% | 35 |
|
|
2023
Q4 | $245M | Sell |
601,514
-88,634
| -13% | -$32.7M | 0.68% | 23 |
|
|
2023
Q3 | $240M | Buy |
690,148
+53,366
| +8% | +$18.7M | 0.74% | 21 |
|
|
2023
Q2 | $224M | Sell |
636,782
-132,845
| -17% | -$44.8M | 0.69% | 22 |
|
|
2023
Q1 | $242M | Buy |
769,627
+96,800
| +14% | +$29M | 0.84% | 18 |
|
|
2022
Q4 | $194M | Buy |
672,827
+270,921
| +67% | +$82.6M | 0.7% | 24 |
|
|
2022
Q3 | $116M | Sell |
401,906
-115,213
| -22% | -$33.1M | 0.46% | 45 |
|
|
2022
Q2 | $146M | Buy |
517,119
+11,535
| +2% | +$3.09M | 0.56% | 31 |
|
|
2022
Q1 | $132M | Buy |
505,584
+259,205
| +105% | +$61.5M | 0.46% | 41 |
|
|
2021
Q4 | $54.1M | Buy |
246,379
+42,137
| +21% | +$8.19M | 0.18% | 136 |
|
|
2021
Q3 | $37M | Sell |
204,242
-91,765
| -31% | -$17.9M | 0.14% | 186 |
|
|
2021
Q2 | $59.7M | Sell |
296,007
-44,854
| -13% | -$9.38M | 0.21% | 115 |
|
|
2021
Q1 | $73.2M | Sell |
340,861
-60,917
| -15% | -$13.4M | 0.3% | 79 |
|
|
2020
Q4 | $95M | Sell |
401,778
-69,579
| -15% | -$16M | 0.44% | 44 |
|
|
2020
Q3 | $128M | Buy |
471,357
+49,013
| +12% | +$13.5M | 0.73% | 21 |
|
|
2020
Q2 | $123M | Buy |
422,344
+39,257
| +10% | +$10.6M | 0.83% | 17 |
|
|
2020
Q1 | $91.2M | Sell |
383,087
-75,427
| -16% | -$17.3M | 0.78% | 16 |
|
|
2019
Q4 | $100M | Sell |
458,514
-61,714
| -12% | -$12.5M | 0.69% | 17 |
|
|
2019
Q3 | $88.1M | Buy |
520,228
+54,976
| +12% | +$9.73M | 0.68% | 18 |
|
|
2019
Q2 | $85.3M | Buy |
465,252
+91,768
| +25% | +$16M | 0.7% | 16 |
|
|
2019
Q1 | $68.7M | Buy |
373,484
+19,618
| +6% | +$3.62M | 0.57% | 27 |
|
|
2018
Q4 | $57.1M | Sell |
353,866
-44,937
| -11% | -$7.79M | 0.53% | 30 |
|
|
2018
Q3 | $76.9M | Buy |
398,803
+46,095
| +13% | +$8.21M | 0.59% | 24 |
|
|
2018
Q2 | $59.9M | Buy |
352,708
+58,841
| +20% | +$9.12M | 0.5% | 26 |
|
|
2018
Q1 | $47.9M | Buy |
293,867
+27,333
| +10% | +$4.46M | 0.4% | 46 |
|
|
2017
Q4 | $39.9M | Buy |
266,534
+74,089
| +38% | +$11M | 0.34% | 60 |
|
|
2017
Q3 | $29.3M | Buy |
192,445
+13,983
| +8% | +$2.1M | 0.25% | 90 |
|
|
2017
Q2 | $23M | Sell |
178,462
-38,836
| -18% | -$4.67M | 0.2% | 115 |
|
|
2017
Q1 | $23.8M | Buy |
217,298
+205,064
| +1,676% | +$18.1M | 0.22% | 99 |
|
|
2016
Q4 | $901K | Sell |
12,234
-85,415
| -87% | -$6.95M | 0.01% | 779 |
|
|
2016
Q3 | $8.52M | Sell |
97,649
-117,315
| -55% | -$11.1M | 0.07% | 369 |
|
|
2016
Q2 | $18.5M | Sell |
214,964
-6,348
| -3% | -$549K | 0.16% | 172 |
|
|
2016
Q1 | $17.6M | Sell |
221,312
-166,086
| -43% | -$15M | 0.15% | 187 |
|
|
2015
Q4 | $48.7M | Sell |
387,398
-17,934
| -4% | -$2.16M | 0.41% | 51 |
|
|
2015
Q3 | $42.2M | Buy |
405,332
+19,096
| +5% | +$2.45M | 0.37% | 54 |
|
|
2015
Q2 | $47.7M | Buy |
386,236
+31,055
| +9% | +$3.91M | 0.39% | 48 |
|
|
2015
Q1 | $41.9M | Buy |
355,181
+268,774
| +311% | +$32.2M | 0.32% | 77 |
|
|
2014
Q4 | $10.3M | Buy |
86,407
+20,832
| +32% | +$2.35M | 0.08% | 300 |
|
|
2014
Q3 | $7.37M | Sell |
65,575
-3,517
| -5% | -$335K | 0.06% | 349 |
|
|
2014
Q2 | $6.54M | Sell |
69,092
-31,404
| -31% | -$2.2M | 0.05% | 397 |
|
|
2014
Q1 | $7.11M | Sell |
100,496
-3,375
| -3% | -$267K | 0.05% | 356 |
|
|
2013
Q4 | $7.72M | Buy |
103,871
+39,929
| +62% | +$2.78M | 0.06% | 322 |
|
|
2013
Q3 | $4.85M | Buy |
63,942
+34,019
| +114% | +$2.71M | 0.04% | 378 |
|
|
2013
Q2 | $2.39M | Buy |
+29,923
| New | +$2.2M | 0.02% | 569 |
|
Other funds holding VRTX
VCM
VPM
BNP Paribas Asset Management's VRTX Position: Q1 2026 in Review
BNP Paribas Asset Management increased its Vertex Pharmaceuticals (VRTX) stake by 27% in Q1 2026, buying an estimated $83.1M and bringing the position to 848,047 shares worth $379M. The position accounts for 0.44% of the portfolio, ranked #36.
BNP Paribas Asset Management first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- BNP Paribas Asset Management held 848,047 shares of Vertex Pharmaceuticals worth $379M as of Q1 2026.
- BNP Paribas Asset Management bought 178,240 Vertex Pharmaceuticals shares in Q1 2026, an estimated $83.1M.
- Vertex Pharmaceuticals made up 0.44% of BNP Paribas Asset Management's portfolio in Q1 2026, its #36 holding.
- BNP Paribas Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.